As those watching the resource space are no doubt aware, the first six months of 2014 saw quite a few junior miners make forays into the medical marijuana sector.

Encouragingly for those companies, swathes of investors have been only too eager to follow. However, many analysts believe that’s a problem, in part because the sector is so new, but also because there’s still so much bureaucratic red tape and uncertainty surrounding marijuana use, even for medical purposes.


It’s thus unsurprising that “caution” and “profit” were the words of the hour at Monday’s Canadian Investor Conference marijuana panel, which featured activist Jodie Emery, Daniel Kiselbach of Deloitte Tax Law, Midas Letter’s James West and Paul Pelosi, Jr. of Verde Science (OTCMKTS:VRCI).

Why be cautious?

Giving his take on the need for caution, West explained that, at least in Canada, there’s a disconnect between what licensed commercial growers think they can achieve and what is actually achievable. Specifically, he said, those growers “predict that they will realize a price of $8 per gram” when “probably 25,000” of the 38,000 medical marijuana users registered with Health Canada “have been on disability and paying less than $1 a gram from compassionate growers and suppliers.”

While that could be a “great opportunit[y]” for traders able to ride stocks up as they’re buoyed by marijuana-related plans, it also means that ultimately there will be a “very slow and consistent degradation for the sector as a whole” as companies that don’t follow through on those plans disappear.

On a similar note, Emery pointed out that companies hoping to grow marijuana “are being promised a marketplace that … does exist,” but is already being served. In her opinion, it will thus be tough for companies to make the money they’ve been promised unless the market expands via “legalization for all” or unless they can “offer something that people can’t get elsewhere.”

Kiselbach was a little more positive, pointing to Tweed Marijuana’s (TSXV:TWD) success after listing on the TSX Venture Exchange and commenting, “there are opportunities, at least at this point in time, for making money.” However, he said, companies must do “careful planning in order to be profitable,” and unfortunately many are not making an effort to do so.

Profitable opportunities

Those comments may sound daunting, but none of the panelists denied that profiting from medical marijuana is indeed possible. Here’s what they said when asked which companies they think are “doing it right.”

  • West: “The best-looking business plan I’ve seen yet belongs to a company called THC Bank, which focuses on protecting and preserving the genetic integrity of various strains of marijuana for growers.”
  • Kiselbach: Kiselbach again identified Tweed as a company that is making money.
  • Emery: Though she noted that she wasn’t there to offer stock picks, Emery did point to her own success at working “in the marijuana industry without actually dealing with marijuana itself.” She also emphasized the importance of supporting companies that advocate for full legalization.
  • Pelosi: “Investors do flock to corporations which have strong corporate governance,” said Pelosi. Additionally, he noted that corporate mission is important, as is growth potential for revenue, a quality he believes Verde Science certainly has.

Certainly some food for thought for investors watching the sector.

Stay tuned for a video interview with Jodie Emery. 

 

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article. 

Related reading: 

Investing in Marijuana: A High-risk Green Rush

Making the Switch: 3 Junior Mining CEOs Explain the Pull of Medical Marijuana

Deloitte Tax Law: What to Look for in a Medical Marijuana Company

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less